2025-11-07 00:15:06
Latest Post
Avalon Technologies Ltd Q2FY26 consolidated net profit at Rs. 24.97 crores
CyberTech Systems and Software Ltd Q2 FY2025-26 consolidated profit at Rs. 8.65 crores
Piramal Pharma Ltd consolidated Q2FY26 loss at Rs. 99.22 crores
Syngene International Ltd Q2FY26 consolidated PAT declines to Rs. 67.1 crores
Magellanic Cloud Ltd Q2 FY2026 consolidated PAT at Rs. 27.61 crores
Stock Report
Colinz Laboratories Ltd Q2FY26 profit at Rs. 14.05 lakhs
Posted On : 2025-11-03 22:35:18( TIMEZONE : IST )
COLINZ LABORATORIES LTD. has reported Standalone financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1.5473 crores during the period ended September 30, 2025 as compared to Rs. 1.6413 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. 0.1405 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 0.1192 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. 0.56 for the period ended September 30, 2025 as compared to Rs. 0.47 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹ 1.5473 crs | ₹1.6413 crs |  -5.73% |
| Net Profit | ₹0.1405 crs | ₹0.1192 crs |  17.87% |
| EPS | ₹0.56 | ₹0.47 | 19.15% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs. 1.5473 crores during the period ended September 30, 2025 as compared to Rs.1.9408 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.0.1405 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.0.1557 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.0.56 for the period ended September 30, 2025 as compared to Rs.0.62 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹ 1.5473 crs | ₹1.9408 crs | -20.28% |
| Net Profit | ₹0.1405 crs | ₹0.1557 crs | -9.76% |
| EPS | ₹0.56 | ₹0.62 | -9.68% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.3.1886 crores during the 6 Months period ended September 30, 2025 as compared to Rs.3.7547 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.0.2597 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.0.2929 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.1.03 for the 6 Months period ended September 30, 2025 as compared to Rs.1.16 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹3.1886 crs | ₹3.7547 crs | -15.08% |
| Net Profit | ₹0.2597 crs | ₹0.2929 crs | -11.33% |
| EPS | ₹1.03 | ₹1.16 | -11.21% |
Shares of COLINZ LABORATORIES LTD. was last trading in BSE at Rs. 42.43 as compared to the previous close of Rs. 41.53. The total number of shares traded during the day was 2560 in over 36 trades.
The stock hit an intraday high of Rs. 45.25 and intraday low of 42.00. The net turnover during the day was Rs. 109653.00.
